In this episode, we explore KarXT, a newly FDA-approved antipsychotic with a groundbreaking cholinergic mechanism, through the lens of a single powerful metric: the Number Needed to Treat. Could an NNT of 5 change how you approach treatment-resistant schizophrenia? Faculty: Oliver Freudenreich, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.75 CMEs: Quick Take Vol. 80 How Effective Is KarXT (Xanomeline-Trospium) for Schizophrenia? NNT and NNH Explained
![<description><p>In this episode, we explore KarXT, a newly FDA-approved antipsychotic with a groundbreaking cholinergic mechanism, through the lens of a single powerful metric: the Number Needed to Treat. Could an NNT of 5 change how you approach treatment-resistant schizophrenia?</p> <p>Faculty: Oliver Freudenreich, M.D.<br /> Host: Richard Seeber, M.D.</p> <ul> <li><a href= "https://psychopharmacologyinstitute.com/cme-program?section=pricing&utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC446" target="_blank" rel="noopener"><strong>Learn more about our membership here</strong></a></li> <li><a href= "https://psychopharmacologyinstitute.com/section/how-effective-is-karxt-xanomeline-trospium-for-schizophrenia-nnt-and-nnh-explained/?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC446" target="_blank" rel="noopener"><strong>Earn 0.75 CMEs: Quick Take Vol. 80</strong></a></li> <li><a href= "https://psychopharmacologyinstitute.com/section/how-effective-is-karxt-xanomeline-trospium-for-schizophrenia-nnt-and-nnh-explained/?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC446" target="_blank" rel="noopener"><strong>How Effective Is KarXT (Xanomeline-Trospium) for Schizophrenia? NNT and NNH Explained</strong></a></li> </ul></description>](https://us-central1-podcastguru-217d6.cloudfunctions.net/gcf_get_image?image_url=https://is1-ssl.mzstatic.com/image/thumb/Podcasts113/v4/a9/69/49/a969490e-d250-e43b-39ed-9a8acc178615/mza_2271515149008366696.png/600x600bb.jpg&width=300&height=300&api_key=xqFmUFX5BHLBTA)